values (SUV) derived from magnetic resonance attenuation correction (MRAC) with those
derived from computed tomography attenuation correction (CTAC) in an oncology patient
population. Procedures The HIPAA-compliant study was approved by the Internal Review
Board and all subjects gave written informed consent prior to inclusion in the study. Forty
patients (mean age 61±15.1; 20 male) referred for clinically indicated 2-deoxy-2-[18 F] fluoro …